Rachel Watkins

Rachel Watkins is currently the Lead Experimental Biologist at CoSyne Therapeutics. Prior to this role, Rachel worked as a Senior Scientist at Horizon Discovery and as a Senior Postdoctoral Research Associate at the Cambridge Institute for Medical Research. Rachel completed their PhD in Biochemistry at the University of Cambridge after earning their Bachelor of Science in Molecular Biology from The University of Edinburgh.